Skinny Label
Subscribe to Skinny Label
Just Skinny Enough: District Court Dismisses Inducement Claims Against Generic "Skinny Label"
By Kathleen DiNapoli & Nicole M. DeAbrantes on January 20, 2022
On January 4, 2022, the District Court for the District of Delaware granted Hikma Pharmaceuticals USA Inc.'s ("Hikma") motion to dismiss Amarin Pharma Inc.'s ("Amarin") infringement claims, finding that Hikma's "skinny label" for its generic heart drug, icosapent ethyl, did not induce infringement of Amarin's three patents. This decision comes on the heels of the…
Federal Circuit Panel Rehears Skinny Label Case (GSK v. Teva)
By Nicole M. DeAbrantes on March 1, 2021
On February 23, 2021, a Federal Circuit panel of Chief Judge Prost, Judge Newman, and Judge Moore reheard oral argument in GlaxoSmithKline LLC v. Teva Pharms. USA, Inc. As discussed in our previous post, on February 9, 2021, the panel issued an order granting Teva's petition for rehearing, vacating the prior October 2,…